Hisgade (Suzhou) Biomedical Technology
Medical device developer and producer of high-end implantable medical devices related to ophthalmic diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD75—113m (Dealroom.co estimates Sep 2022.)
Suzhou Shi Jiangsu (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
CNY100m | Seed | ||
* | CNY100m | Series A | |
* | N/A | Series B | |
| Total Funding | CAD37.5m | ||